Materias dentro de su búsqueda.
Mostrando 926,401 - 926,420 Resultados de 928,171 Para Buscar '"8½"', tiempo de consulta: 4.67s Limitar resultados
  1. 926401
    “…Au moins une comorbidité est présente chez 14609 (39%) volontaires: 16% d’obésité (n = 6054), 16,5 % d’hypertension artérielle (n = 6243), 6% de diabète (n = 2251), 6,6% de maladie cardiaque (n = 2493), 9,9% de maladie respiratoire (n = 3747), 0,4 % d’insuffisance rénale (n = 160), 5,2 % de maladie auto-immune (n = 1976), 0,8% de cancer (n = 306) et 0,3% de transplantés (n = 117). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Caractéristiques des volontaires inscrits sur la plateforme nationale dédiée aux essais vaccinaux COVID-19
  2. 926402
    “…The median length of hospital stay was 9.4 days (interquartile range, 8.1 to 13.3). There were no deaths - all patients were discharged home. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital
  3. 926403
    “…Methods: This retrospective cohort study included KPNC adult members (≥18 years) with positive COVID-19 testing between February 25,2020, and May 8,2020. Patients were stratified based on electronic medical records indicating a filled prescription or actively taking antiplatelets or anticoagulants within 90 days prior to COVID-19 diagnosis. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients
  4. 926404
    “…Free-text responses about the impact of COVID-19 on MPN care were 49% (n=400) negative, 21% (n=177) positive, 8% (n=65) both positive and negative, and 22% (n=182) neutral/no impact. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care
  5. 926405
    “…Twelve (57.4%) were never hospitalized (4/7 auto and 8/14 allo-HSCT) with a median age of 32.5 (range, 16-70). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care
  6. 926406
    “…Incidence of 6.3% VTE, 5.6% DVT, 4.8% PE in COVID-19 patients was significantly higher than 0.24% VTE, 0.15% DVT, 0.12% PE in non COVID-19 hospitalized patients as reported by CDC (p<.0001 for all). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
  7. 926407
    “…Statistical analysis was performed using GraphPad Prism (v8.4.3, GraphPad Software, San Diego, CA) and R (v4, R Core Team, 2020). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
  8. 926408
    “…For patients with cancer, NICE recommend delivering systemic anti-cancer treatment in different and less immunosuppressive regimens, different locations (ideally at home) or via another (less invasive and/or less resource intensive) route of administration where possible.(8)(9) The objective of this analysis is to explore the impact of switching patients from intravenous (IV) treatments requiring hospital administrations to subcutaneous (SC) or oral alternatives which can be administered at home or in an outpatient setting which reduces the patient's potential exposure to COVID-19. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Delivering Systemic Anti-Cancer Treatment Via Another Route of Administration As an Option to Reduce Exposure to COVID-19 in Patients with Multiple Myeloma in the UK
  9. 926409
    “…Most patients received anti-viral treatment with either hydroxichloroquine (47 patients, 54%), lopinavir/ritonavir (34 patients, 39%), remdesivir (5, 4%) and/or other treatments including azythromicin or interferon. 23 patients (26%) received anticytokine treatment with tocilizumab (15, 17%) and/or anakinra (8, 9%) and 27 patients (31%) received steroids. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group
  10. 926410
    “…During the study period, RC made 308 and received 1,797 calls (2,105 contacts), generating 242 (11.5%) screening appointments, 173 (8.2%) of which resulted from self-referral and 69 (3.2%) from active search. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Challenge of Recruiting Convalescent Plasma Donors during the COVID-19 Pandemic: Preliminary Results from a Single Center in Midwest Brazil
  11. 926411
    “…Tocilizumab was given to 8 pts. Twelve pts required oxygen supply and 7 required ICU support (median stay 16 [1-47] days). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups
  12. 926412
    “…Next, we compared development of thromboembolism during hospital stay in the A, AB, B, and O blood type groups and the rate was 8%, 11.1%, 9.3%, and 10.9% respectively with the results not being statistically significant when accounted for blood type (p=0.991). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population
  13. 926413
    “…Results: In the derivation cohort, compensated DIC was diagnosed in 8.2% of patients in the C-group and in 28.2% of patients in the W-group (p=0.001). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19
  14. 926414
    “…Regarding laboratory values, patients on therapeutic doses had higher leucocytes on admission (median 6 x 109L, 6 and 8, p=0.05) but lower lymphocyte absolute counts (median 1240 cells/mm3, 935 and 920, p<0.001). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
  15. 926415
    “…The same two authors reviewed the full text of the remaining articles and excluded those that met the following exclusion criteria: 1) not peer-reviewed; 2) not written in English; 3) did not include unique primary data; 4) no defined study time interval; 5) did not describe and quantify hospitalized patients with confirmed diagnosis of COVID-19; 6) did not describe a consecutive case series or consecutive cohort studies or controlled trials with consecutive enrollment of subjects that met specific inclusion criteria; 7) study inclusion criteria were related to the clinical suspicion for VTE; 8) did not describe a method whereby clinically detected VTE was tabulated; 9) did not report the VTE incidence (PE, DVT, or both) among the specified study population. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review
  16. 926416
    “…Seven-week-old CD-1 female mice were randomly allocated to four experimental groups: Control (n = 13), chemotherapy (ChT, n = 15), ChT+LH-1x (n = 15), and ChT+LH-5x (n = 8). To induce primary ovarian insufficiency (POI), animals in the ChT and ChT+LH groups were intraperitoneally injected with 120 mg/kg of cyclophosphamide and 12 mg/kg of busulfan, while control mice received vehicle. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model
  17. 926417
    “…The primary outcome of mean HbA1c at 12 months (CON 48.5 (9.1) mmol/mol, INT 46.5 (8.1) mmol/mol, and INT-DPM 45.6 (6.0) mmol/mol) was significantly lower in the INT-DPM arm compared to CON (adjusted difference −2.57 mmol/mol; 95% CI −4.5, −0.6; p = 0.007) but not significantly different between the INT-DPM and INT arms (−0.55 mmol/mol; 95% CI −2.46, 1.35; p = 0.57), or INT vs CON arms (−2.14 mmol/mol; 95% CI −4.33, 0.05; p = 0.07). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected type 2 diabetes: a randomised controlled trial
  18. 926418
    “…In addition, there were clause of fulfillment of readiness criteria at each sentinel site (already described in the line no 171 to 180 at page no-8, 181–189 at page no-9 and 192–212 at page no-10). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India
  19. 926419
    “…Overall, the IC Temperament factor and other covariates together accounted for 22.5% of the variance in vocabulary, whereas IC-Stroop and other controlled variables could explain 49.8% of the variance in WM. These findings indicate that theoretical perspectives (in this case temperament and EF IC contexts) and the different types of assessments used are crucial considerations when interpreting the results of studies of early childhood IC. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Multi-Theoretical and Multi-Method Family Study Approach to Preschool Inhibitory Control: Links to Working Memory, Receptive Vocabulary, Behavioral Maladjustment, and Parent Mental Health in the Context of Temperament and Executive Functioning Perspectives
  20. 926420
    por Wood, Angela, Denholm, Rachel, Hollings, Sam, Cooper, Jennifer, Ip, Samantha, Walker, Venexia, Denaxas, Spiros, Akbari, Ashley, Banerjee, Amitava, Whiteley, William, Lai, Alvina, Sterne, Jonathan, Sudlow, Cathie, Douiri, Abdel, Akinoso-Imran, Abdul Qadr, Jonas, Adrian, Shah, Ajay, Handy, Alex, Davies, Alun, Kurdi, Amanj, Hansell, Anna, Docherty, Annemarie, Pherwani, Arun, Dashtban, Ashkan, Bray, Ben, Cairns, Ben, Goldacre, Ben, Humberstone, Ben, Mateen, Bilal, Doble, Brett, Roberts, Brian, Morris, Carole, Dale, Caroline, Rogers, Caroline, Wolfe, Charles, Tomlinson, Christopher, Lawson, Claire, du Toit, Clea, Berry, Colin, Smith, Craig, O’Connell, Dan, Harris, Daniel, Brind, David, Cromwell, David, Hughes, David, Martos, David Moreno, Ringham, Debbie, Lawler, Deborah, Lowe, Deborah, Nikiphorou, Elena, Withnell, Eloise, Di Angelantonio, Emanuele, Morris, Eva, Birney, Ewan, Falck, Fabian, Torabi, Fatemeh, Greaves, Felix, Falter, Florian, Zaccardi, Francesco, Kee, Frank, Davies, Gareth, Nicholson, George, Curry, Gwenetta, Zhang, Haoting, Hemingway, Harry, Wilde, Harry, Abbasizanjani, Hoda, Wu, Honghan, Tang, Howard, Wang, Huan, Mordi, Ify, MacArthur, Jackie, Lyons, Jane, Beveridge, Jennifer, Barrett, Jessica, Wu, Jianhua, Thygesen, Johan, Danesh, John, Dennis, John, Boyle, Jon, Halcox, Julian, Khunti, Kamlesh, Cheema, Kate, Brown, Katherine, Li, Ken, Kavanagh, Kim, North, Laura, Pasea, Laura, Ellins, Libby, Pierotti, Livia, Wright, Lucy, Martin, Lydia, Morrice, Lynn, Mamas, Mamas, Bennie, Marion, Barber, Mark, Macleod, Mary Joan, Caputo, Massimo, Buch, Maya, Mizani, Mehrdad, Katsoulis, Michalis, Gravenor, Mike, Inouye, Mike, Skrypak, Mirek, Gerstung, Moritz, Pirmohamed, Munir, Glickman, Myer, Herz, Naomi, Davies, Neil, Hall, Nick, Samani, Nilesh, Seminog, Olena, Lorgelly, Paula, Machado, Pedro, Li, Qiuju, Denholm, Rachel, Goldacre, Raph, Carragher, Raymond, Sofat, Reecha, Takhar, Rohan, Lyons, Ronan, Priedon, Rouven, Griffiths, Rowena, Payne, Rupert, Kolamunnage-Dona, Ruwanthi, Salim, Safa, Padmanabhan, Sandosh, Onida, Sarah, Kent, Seamus, Bacon, Seb, Manohar, Sinduja, Babu-Narayan, Sonya, Keene, Spencer, Varma, Susheel, Lawrence, Thomas, Wang, Tianxiao, Wilkinson, Tim, Norris, Tom, Palmer, Tom, Nafilyan, Vahé
    Publicado 2021
    “…Among 53.2 million people with no previous diagnosis of myocardial infarction, 62 966 had an incident myocardial infarction during follow-up, of which 8% were recorded only in primary care and 12% only in death registry records. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource
Herramientas de búsqueda: RSS